Why GLP-1 Agonists May Not Be Safe for People with Type 1 Diabetes Eric Han Feb 23 4 min read GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity
Prevalence of fecal incontinence in diabetic patients: epidemiological study of patients assisted as outpatients at the Clinical Hospital of the Medical School at the University of So Paulo
doi:10.3390/antiox12071375 About the Author Nayan Patel, PharmD Nayan Patel, PharmD, is a sought-after pharmacist, wellness expert, and thought leader in the antiaging industry
Thymosin Beta-4 may accelerate healing from traumatic brain injury (TBI) A 2012 paper reported rapid cognitive recovery in rats with traumatic brain injury (TBI) [9]
Net price, not list price, is the correct input for IP DCF models